Octopamine signaling in the metazoan pathogenSchistosoma mansoni: localization, small-molecule screening and opportunities for drug development
Open Access
- 1 July 2018
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 11 (7) , dmm033563
Abstract
Schistosomiasis is a tropical disease caused by a flatworm trematode parasite that infects over 200 million people worldwide. Treatment and control of the disease rely on just one drug, praziquantel. The possibility of drug resistance coupled with praziquantel9s variable efficacy encourages the identification of new drugs and drug targets. Disruption of neuromuscular homeostasis in parasitic worms is a validated strategy for drug development. In schistosomes, however, much remains to be understood about the organization of the nervous system, its component neurotransmitters and potential for drug discovery. Using synapsin as a neuronal marker, we map the central and peripheral nervous systems in the Schistosoma mansoni adult and schistosomulum (post-infective larva). We discover the widespread presence of octopamine (OA), a tyrosine-derived and invertebrate-specific neurotransmitter involved in neuromuscular coordination. OA labeling facilitated the discovery of two pairs of ganglia in the brain of the adult schistosome, rather than the one pair thus far reported for this and other trematodes. In quantitative phenotypic assays, OA and the structurally related tyrosine-derived phenolamine and catecholamine neurotransmitters differentially modulated schistosomulum motility and length. Similarly, from a screen of 28 drug agonists and antagonists of tyrosine-derivative signaling, certain drugs that act on OA and dopamine receptors induced robust and sometimes complex concentration-dependent effects on schistosome motility and length; in some cases, these effects occurred at concentrations achievable in vivo. The present data advance our knowledge of the organization of the nervous system in this globally important pathogen and identify a number of drugs that interfere with tyrosine-derivative signaling, one or more of which might provide the basis for a new chemotherapeutic approach to treat schistosomiasis. This article has an associated First Person interview with the first author of the paper.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (169998-2012)
- Fonds de Recherche du Québec - Nature et Technologies
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- The Company of Biologists
This publication has 166 references indexed in Scilit:
- The effect of octopaminergic compounds on the behaviour and transmission of GyrodactylusParasites & Vectors, 2011
- Schistosome I/Lamides – A new family of bioactive helminth neuropeptidesInternational Journal for Parasitology, 2011
- Neuronal signaling in schistosomes: current status and prospects for postgenomicsThe present review is one of a series of occasional review articles that have been invited by the Editors and will feature the broad range of disciplines and expertise represented in our Editorial Advisory Board.Canadian Journal of Zoology, 2010
- Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoniPLOS Neglected Tropical Diseases, 2009
- Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic ScreeningPLOS Neglected Tropical Diseases, 2009
- α2A‐Adrenergic Receptor Signaling Underlies Synergistic Enhancement of Ethanol‐Induced Behavioral Impairment by ClonidineAlcohol, Clinical and Experimental Research, 2009
- Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis TreatmentPLOS Neglected Tropical Diseases, 2009
- Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychoticsProceedings of the National Academy of Sciences, 2008
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006
- Serotonin and Octopamine in the Nematode Caenorhabditis elegansScience, 1982